FDA Inspection 1071869 — B & B Pharmaceuticals, Inc.
The FDA completed an inspection of B & B Pharmaceuticals, Inc. on Oct 30, 2018 in Englewood, CO. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Oct 30, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Englewood, CO (United States)